Austria: Cannabidiol In Food And Cosmetics

Last Updated: 8 July 2019
Article by Rainer Herzig
Most Popular Article in Austria, July 2019

Introduction

The marketing of cannabidiol (CBD) extracts as food supplements is a relatively new trend and CBD is increasingly common in the food and beverage sector (e.g., in sweets, cakes and beer). Hemp contains approximately 60 cannabinoids, including the psychotropic tetrahydrocannabinol (THC) and the non-psychotropic CBD. Although there are no long-term studies on how it affects health, experts have argued that CBD can have anxiolytic, neuroprotective, anti-psychotic, antiinflammatory, anti-spasmodic effects.

While there are signs of greater liberalization with respect to hemp use internationally, the Austrian government has resisted this trend. Under the Controlled Substances Act and the Controlled Substances Regulation only cannabis resin and cannabis inflorescence and infructescence with a THC concentration of more than 0,3 % THC qualify as narcotics. The active substance THC may be used in pharmaceuticals, whereas the use of the hemp blossom as a drug is not permitted. The other parts of hemp plants- such as seed, leaves and cannabinoids contained therein (except for THC) – do not qualify as narcotics.

Decree

In October 2018 the ministry of Labour, Social Affairs, Health and Consumer Protection published a decree1 outlining its legal opinion on product regulations which prohibit CBD use in food and cosmetics. While such decrees are only internal administrative instructions, the ministry published this decree in a press release and on its website for public effect.

According to the decree products derived from the inflorescence and infructescence of certain hemp species are excluded from narcotics legislation

  • if their THC-content does not exceed 0,3 %; and
  • the production of narcotics in a concentration that could be misappropriated in a simple or economic manner is not possible.

The ministry considers extracts containing cannabinoid used in food (primarily in food supplements such as CBD oil) generally as novel food according to Regulation (EU) 2015/2283 and therefore not marketable, since there is no marketing authorization for such products.2 Both the Community Code relating to medicinal products3 and the Austrian Act on Medicinal Products4 distinguish whether or not a product is a medicinal product basically between medicinal products by function and medicinal products by presentation. A medicinal product by function has a significant influence on the human physiological functions by a pharmacological effect in connection with the prevention or treatment of a disease or has a medical-therapeutical benefit5 . According to the ministry the published data on the application of CBD in a recent pubmed-research are not sufficient for the assessment of a therapeutic effect. CBD therefore is not a medicinal product by function. A qualification of CBDcontaining extracts as medicinal products can be considered only if preventive, healing or remedial properties are attributed to such products (medicinal product by presentation). 6

The ministry therefore considers a marketing of food products containing CBD as not permitted.

In respect of the use of Cannabis sativa L. and its extracts in cosmetics, the ministry refers to Article 14 (1) (a) in connection with Appendix II (306) of Regulation (EC) 1223/2009 on cosmetic products. Article 14 (1) (a) prohibits the use of the substances listed in Appendix II and Appendix II lists "natural and synthetic narcotics", which are defined as any substance listed in Schedules I and II of the Single Convention on Narcotic Drugs of 1961 which includes Cannabis and its extracts. Therefore, the ministry also considers a marketing of cannabis and its extracts in cosmetics as not permitted.

Comment

The apodictic qualification of CBD products as novel food respectively as medicinal product by presentation by the ministry is questionable.

It is true that the EU Novel Food Catalogue7 qualifies extracts of Cannabis sativa L. and derived products containing cannabinoids as novel foods as a history of consumption has not been demonstrated.

However, with regard to the hemp plant (Cannabis sativa L.) itself the catalogue states:

"In the European Union, the cultivation of Cannabis sativa L. varieties is permitted provided they are registered in the EU's common catalogue of varieties of agricultural plants species and the THC content does not exceed 0,2 %. Some products derived from the Cannabis sativa plant or plant parts such as seeds, seed oil, hemp seed flour, defatted hemp seed have a history of consumption in the EU and therefore, are not novel. Other specific national legislation may restrict the placing on the market of this product as a food or food ingredient in some member states. Therefore, it is recommended to check with the national competent authorities."

Contrary to the ministry's decree Cannabis sativa L. and seeds, seed oil, hemp seed flower and defatted hemp seed are not novel. The oil obtained from the hemp plant by cold-pressing the seeds naturally contains low levels of CBD. Numerous hempand CBD-containing foods such as teas, oils and flour are not novel and therefore are not subject to the novel food regulation. They are also not medicinal products by presentation as long as no preventive, healing or remedial properties are attributed to products containing these ingredients (e.g. hemp oil or hemp seed oil derived from the hemp plant) and can be marketed as food supplements.

Also, the assessment of the use of CBD in cosmetics is questionable. Contrary to the impression created by the decree, the EU regulation on cosmetics does not contain a general prohibition on CBD use in cosmetics. Irrespective of its source, CBD per se is not listed in the schedules of the Single Convention on Narcotic Drugs, however, the schedules list cannabis and cannabis resin, extracts and tinctures. According to the convention, CBD in cosmetic products is prohibited only, if it is prepared from cannabis resin, extract or tincture.

Therefore, rather than providing legal certainty, the ministry's decree merely reflects headlines relating to the government's narcotics program ("prohibition of the sale of hemp seed and hemp plants" and "tightening of certain provisions in the narcotics act").

Footnotes

1 BMASGK-75100/0020-IX/B/16a/2018.

2 There is an application to use CBD extract in food supplements pending since 2016.

3 Directive (EU) 2001/83.

4 BGBl 185/1983 as amended.

5 ECJ C-358/13; ECJ C-181/14.

6 In the absence of a marketing authorization such products may not be marketed.

7 ec.europa.eu/food/safety/novel_food/catalogue/search/public/index.cfm#

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Schoenherr Attorneys at Law
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Schoenherr Attorneys at Law
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions